BeyondSpring
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BeyondSpring and other ETFs, options, and stocks.About BYSI
BeyondSpring, Inc. engages in the development and commercialization of immuno-oncology cancer therapies. It operates through the Plinabulin Pipeline and TPD Platform segments.
BYSI Key Statistics
Stock Snapshot
BeyondSpring(BYSI) stock is priced at $1.87, giving the company a market capitalization of 76.49M. It carries a P/E multiple of -4.97.
On 2025-12-17, BeyondSpring(BYSI) stock traded between a low of $1.85 and a high of $1.93. Shares are currently priced at $1.87, which is +1.1% above the low and -3.1% below the high.
The BeyondSpring(BYSI)'s current trading volume is 95.97K, compared to an average daily volume of 1.29M.
In the last year, BeyondSpring(BYSI) shares hit a 52-week high of $3.44 and a 52-week low of $0.98.
In the last year, BeyondSpring(BYSI) shares hit a 52-week high of $3.44 and a 52-week low of $0.98.
BYSI News
Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...
BeyondSpring (BYSI) announced results from the Asian subset of its global Phase 3 DUBLIN-3 trial evaluating Plinabulin plus docetaxel compared to docetaxel alon...
BeyondSpring (BYSI) announced new post-hoc analyses from its global Phase 3 DUBLIN-3 Study showing that Plinabulin plus docetaxel provides clinically meaningful...